BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 15907911)

  • 1. Targeting the mast cell in asthma.
    Peachell P
    Curr Opin Pharmacol; 2005 Jun; 5(3):251-6. PubMed ID: 15907911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of adenosine and anti-IgE antibody on histamine release from mast cells in BALF of asthma patients].
    Xie H; He SH; Chen P
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2003 Sep; 19(5):503-5. PubMed ID: 15169670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Caspase-dependent and -independent apoptosis of mast cells induced by withdrawal of IL-3 is prevented by Toll-like receptor 4-mediated lipopolysaccharide stimulation.
    Yoshikawa H; Tasaka K
    Eur J Immunol; 2003 Aug; 33(8):2149-59. PubMed ID: 12884289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-immunoglobulin E treatment with omalizumab in allergic diseases: an update on anti-inflammatory activity and clinical efficacy.
    Holgate ST; Djukanović R; Casale T; Bousquet J
    Clin Exp Allergy; 2005 Apr; 35(4):408-16. PubMed ID: 15836747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting mast cells: Uncovering prolific therapeutic role in myriad diseases.
    Singh J; Shah R; Singh D
    Int Immunopharmacol; 2016 Nov; 40():362-384. PubMed ID: 27694038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-IgE as a mast cell-stabilizing therapeutic agent.
    Chang TW; Shiung YY
    J Allergy Clin Immunol; 2006 Jun; 117(6):1203-12; quiz 1213. PubMed ID: 16750976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Agents against cytokine synthesis or receptors.
    Yamagata T; Ichinose M
    Eur J Pharmacol; 2006 Mar; 533(1-3):289-301. PubMed ID: 16457805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Asthma therapy: basic mechanisms.
    Barnes PJ
    Eur J Respir Dis Suppl; 1986; 144():217-65. PubMed ID: 2874993
    [No Abstract]   [Full Text] [Related]  

  • 9. Are mast cells all bad?
    Page CP
    Postgrad Med J; 1991; 67 Suppl 4():S6-11; discussion S12. PubMed ID: 1684662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-IgE therapy.
    Brownell J; Casale TB
    Immunol Allergy Clin North Am; 2004 Nov; 24(4):551-68, v. PubMed ID: 15474858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of mast cells by double-stranded RNA: evidence for activation through Toll-like receptor 3.
    Kulka M; Alexopoulou L; Flavell RA; Metcalfe DD
    J Allergy Clin Immunol; 2004 Jul; 114(1):174-82. PubMed ID: 15241362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toll-like receptor-mediated activation of mast cells: implications for allergic disease?
    Marshall JS; McCurdy JD; Olynych T
    Int Arch Allergy Immunol; 2003 Oct; 132(2):87-97. PubMed ID: 14600420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renaissance of the effector role of the mast cell in bronchial asthma.
    Polosa R
    Ann Ital Med Int; 1995; 10(2):126-33. PubMed ID: 7619653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New targets for modifying mast cell activation in asthma.
    Ennis M
    Curr Allergy Asthma Rep; 2006 May; 6(3):247-51. PubMed ID: 16579876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toll-like receptor 4-mediated activation of murine mast cells.
    McCurdy JD; Lin TJ; Marshall JS
    J Leukoc Biol; 2001 Dec; 70(6):977-84. PubMed ID: 11739561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can anti-IgE therapy prevent airway remodeling in allergic asthma?
    Rabe KF; Calhoun WJ; Smith N; Jimenez P
    Allergy; 2011 Sep; 66(9):1142-51. PubMed ID: 21645010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Asthma, adenosine, mast cells and theophylline.
    Coward WR; Sagara H; Church MK
    Clin Exp Allergy; 1998 Aug; 28 Suppl 3():42-6. PubMed ID: 9756185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of human cord blood-derived mast cell responses by anti-Fc epsilon RI mAb 15/1 versus anti-IgE Omalizumab.
    Mirkina I; Schweighoffer T; Kricek F
    Immunol Lett; 2007 Apr; 109(2):120-8. PubMed ID: 17368811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subcutaneous prostaglandin E(2) restrains airway mast cell activity in vivo and reduces lung eosinophilia and Th(2) cytokine overproduction in house dust mite-sensitive mice.
    Herrerias A; Torres R; Serra M; Marco A; Roca-Ferrer J; Picado C; de Mora F
    Int Arch Allergy Immunol; 2009; 149(4):323-32. PubMed ID: 19295236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PGE suppresses excessive anti-IgE induced cysteinyl leucotrienes production in mast cells of patients with aspirin exacerbated respiratory disease.
    Wang XS; Wu AY; Leung PS; Lau HY
    Allergy; 2007 Jun; 62(6):620-7. PubMed ID: 17508965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.